nach oben

Medical Oncology

Erschienen in:

01.03.2013 | Letter to the Editor

A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine

verfasst von: Hamid Shaaban, Erin Downs, Payam Shakouri, Gunwant Guron

Erschienen in: Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Fluoropyrimidine compounds, with 5-fluorouracil (5-FU) as their principal representative, have been the mainstay of chemotherapy for solid tumors for over 40 years. 5-FU, either as monotherapy or in combination with other cytotoxic agents, is used in many standard treatment regimens for common solid tumors, including breast and colorectal cancers [1, 2]. …

Lokich J, Ahlgren J, Gullo J, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic oncology program study. J Clin Oncol. 1989;7:425–32.PubMed

Poon MA, O’Connell MJ, Moertel CG, et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol. 1989;7:1407–18.PubMed

Doll DC, Weiss RB. Hemolytic anemia associated with antineoplastic agents. Cancer Treat Rep. 1985;69:777–82.PubMed

Wenzel C, Mader RM, Steger GG, et al. Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignancies. Anticancer Drugs. 2003;14:119–23.PubMedCrossRef

Titel: A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine
verfasst von: Hamid Shaaban
Erin Downs
Payam Shakouri
Gunwant Guron
Publikationsdatum: 01.03.2013
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 1/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-012-0321-x

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Prognostic significance of BRCA1 expression in gastric cancer

AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis

Treatment with sorafenib and sunitinib in renal cell cancer: a Swedish register-based study

Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women

Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie